Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of ZENLABS ETHICA. For more details, see the ZENLABS ETHICA quarterly results and ZENLABS ETHICA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.2 |
No. of shares | m | 6.51 |
1 Week | % | 2.4 |
1 Month | % | -1.2 |
1 Year | % | -31.9 |
52 week H/L | Rs | 70.0/31.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ZENLABS ETHICA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 142 | 64 | 39 | 55 | 83 | |
Low | Rs | 35 | 18 | 19 | 19 | 27 | |
Sales per share (Unadj.) | Rs | 103.4 | 92.1 | 87.0 | 106.1 | 102.7 | |
Earnings per share (Unadj.) | Rs | 1.9 | -1.3 | 1.2 | 1.2 | 0.8 | |
Diluted earnings per share | Rs | 1.9 | -1.3 | 1.2 | 1.2 | 0.8 | |
Cash flow per share (Unadj.) | Rs | 2.3 | -0.9 | 2.3 | 2.6 | 2.7 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0.25 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0.5 | |
Book value per share (Unadj.) | Rs | 12.7 | 11.4 | 13.2 | 14.3 | 14.9 | |
Adj. book value per share | Rs | 12.7 | 11.4 | 13.2 | 14.3 | 14.9 | |
Shares outstanding (eoy) | m | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 | |
Price / Sales ratio | x | 0.9 | 0.4 | 0.3 | 0.3 | 0.5 | |
Avg P/E ratio | x | 45.5 | -30.8 | 24.5 | 30.9 | 73.2 | |
P/CF ratio (eoy) | x | 38.6 | -46.4 | 12.7 | 14.4 | 20.6 | |
Price / Book Value ratio | x | 6.9 | 3.6 | 2.2 | 2.6 | 3.7 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 33.3 | |
Avg Mkt Cap | Rs m | 575 | 267 | 188 | 242 | 358 | |
Total wages/salary | Rs m | 33 | 32 | 34 | 39 | 43 |
ZENLABS ETHICA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 673 | 599 | 566 | 691 | 669 | |
Other income | Rs m | 2 | 1 | 1 | 1 | 1 | |
Total revenues | Rs m | 675 | 600 | 568 | 692 | 670 | |
Gross profit | Rs m | 20 | -7 | 17 | 24 | 23 | |
Depreciation | Rs m | 2 | 3 | 7 | 9 | 12 | |
Interest | Rs m | 1 | 2 | 3 | 4 | 5 | |
Profit before tax | Rs m | 19 | -12 | 9 | 12 | 7 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 6 | -3 | 1 | 4 | 2 | |
Profit after tax | Rs m | 13 | -9 | 8 | 8 | 5 | |
Gross profit margin | % | 3.0 | -1.2 | 3.1 | 3.5 | 3.5 | |
Effective tax rate | % | 33.2 | 25.8 | 10.8 | 36.0 | 27.4 | |
Net profit margin | % | 1.9 | -1.4 | 1.4 | 1.1 | 0.7 |
ZENLABS ETHICA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 328 | 318 | 275 | 334 | 375 | |
Current liabilities | Rs m | 261 | 259 | 215 | 252 | 295 | |
Net working cap to sales | % | 10.0 | 9.9 | 10.7 | 11.9 | 12.0 | |
Current ratio | x | 1.3 | 1.2 | 1.3 | 1.3 | 1.3 | |
Inventory Days | Days | 4 | 4 | 5 | 4 | 4 | |
Debtors Days | Days | 135,379,697 | 135,423,769 | 1,217 | 1,096 | 1,184 | |
Net fixed assets | Rs m | 21 | 18 | 43 | 43 | 58 | |
Share capital | Rs m | 65 | 65 | 65 | 65 | 65 | |
"Free" reserves | Rs m | 18 | 9 | 21 | 28 | 32 | |
Net worth | Rs m | 83 | 74 | 86 | 93 | 97 | |
Long term debt | Rs m | 3 | 3 | 2 | 2 | 11 | |
Total assets | Rs m | 349 | 336 | 318 | 377 | 433 | |
Interest coverage | x | 26.9 | -4.0 | 4.0 | 4.3 | 2.3 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0.1 | |
Sales to assets ratio | x | 1.9 | 1.8 | 1.8 | 1.8 | 1.5 | |
Return on assets | % | 3.8 | -1.9 | 3.3 | 3.1 | 2.4 | |
Return on equity | % | 15.3 | -11.7 | 9.0 | 8.4 | 5.0 | |
Return on capital | % | 22.9 | -12.1 | 13.0 | 16.8 | 11.2 | |
Exports to sales | % | 0.6 | 1.1 | 1.5 | 0 | 0 | |
Imports to sales | % | 2.8 | 0 | 2.1 | 0 | 0 | |
Exports (fob) | Rs m | 4 | 7 | 9 | 0 | 0 | |
Imports (cif) | Rs m | 19 | 0 | 12 | 0 | 0 | |
Fx inflow | Rs m | 4 | 7 | 9 | 0 | 0 | |
Fx outflow | Rs m | 19 | 0 | 12 | 0 | 0 | |
Net fx | Rs m | -15 | 7 | -3 | 0 | 0 |
ZENLABS ETHICA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 8 | 5 | -84 | -4 | 15 | |
From Investments | Rs m | -2 | 0 | 2 | 0 | -15 | |
From Financial Activity | Rs m | -1 | -0 | -5 | 3 | 1 | |
Net Cashflow | Rs m | 4 | 4 | -88 | -1 | 1 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Sanjeev Kumar | COMP SEC: Akshay saxena | YEAR OF INC: 1993 | BSE CODE: 530697 | FV (Rs): 10 | DIV YIELD (%): 0.6 |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ZENLABS ETHICA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.